Literature DB >> 16378988

Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6.

Keigo Machida1, Kevin T H Cheng, Vicky M-H Sung, Alexandra M Levine, Steven Foung, Michael M C Lai.   

Abstract

Hepatitis C virus (HCV) induces inflammatory signals, leading to hepatitis, hepatocellular carcinomas, and lymphomas. The mechanism of HCV involvement in the host's innate immune responses has not been well characterized. In this study, we analyzed expression and regulation of the entire panel of toll-like receptors (TLRs) in human B cells following HCV infection in vitro. Among all of the TLRs (TLRs 1 to 10) examined, only TLR4 showed an altered expression (a three- to sevenfold up-regulation) after HCV infection. Peripheral blood mononuclear cells from HCV-infected individuals also showed a higher expression level of TLR4 compared with those of healthy individuals. HCV infection significantly increased beta interferon (IFN-beta) and interleukin-6 (IL-6) secretion from B cells, particularly after lipopolysaccharide stimulation. The increased IFN-beta and IL-6 production was mediated by TLR4 induction, since the introduction of the small interfering RNA against TLR4 specifically inhibited the HCV-induced cytokine production. Among all of the viral proteins, only NS5A caused TLR4 induction in hepatocytes and B cells. NS5A specifically activated the promoter of the TLR4 gene in both hepatocytes and B cells. In conclusion, HCV infection directly induces TLR4 expression and thereby activates B cells, which may contribute to the host's innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16378988      PMCID: PMC1346849          DOI: 10.1128/JVI.80.2.866-874.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection.

Authors:  L Caradonna; M L Mastronardi; T Magrone; R Cozzolongo; R Cuppone; O G Manghisi; D Caccavo; N M Pellegrino; A Amoroso; E Jirillo; L Amati
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

2.  RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication.

Authors:  Rama M Surabhi; Richard B Gaynor
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.

Authors:  Eileen Foy; Kui Li; Chunfu Wang; Rhea Sumpter; Masanori Ikeda; Stanley M Lemon; Michael Gale
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

4.  Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.

Authors:  Dagmar Schilling; Karen Thomas; Kathryn Nixdorff; Stefanie N Vogel; Matthew J Fenton
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

5.  Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Authors:  Yong-Han Paik; Robert F Schwabe; Ramón Bataller; Maria P Russo; Christian Jobin; David A Brenner
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

6.  TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.

Authors:  Vladimir Toshchakov; Bryan W Jones; Pin-Yu Perera; Karen Thomas; M Joshua Cody; Shuling Zhang; Bryan R G Williams; Jennifer Major; Thomas A Hamilton; Matthew J Fenton; Stefanie N Vogel
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

7.  Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis.

Authors:  Tobias Manigold; Ulrich Böcker; Christoph Hanck; Jutta Gundt; Petra Traber; Christoph Antoni; Siegbert Rossol
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-03       Impact factor: 2.566

Review 8.  IL-6 in autoimmune disease and chronic inflammatory proliferative disease.

Authors:  Katsuhiko Ishihara; Toshio Hirano
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

9.  Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.

Authors:  Vicky M-H Sung; Shigetaka Shimodaira; Alison L Doughty; Gaston R Picchio; Huong Can; T S Benedict Yen; Karen L Lindsay; Alexandra M Levine; Michael M C Lai
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  75 in total

Review 1.  Hepatic stellate cells and innate immunity in alcoholic liver disease.

Authors:  Yang-Gun Suh; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

Authors:  João-Bruno Soares; Pedro Pimentel-Nunes; Roberto Roncon-Albuquerque; Adelino Leite-Moreira
Journal:  Hepatol Int       Date:  2010-10-21       Impact factor: 6.047

Review 3.  Conceptual importance of identifying alcoholic liver disease as a lifestyle disease.

Authors:  Hidekazu Tsukamoto
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

Review 4.  Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer.

Authors:  Clodoveo Ferri; Marco Sebastiani; Dilia Giuggioli; Michele Colaci; Poupak Fallahi; Alessia Piluso; Alessandro Antonelli; Anna Linda Zignego
Journal:  World J Hepatol       Date:  2015-03-27

5.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 6.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 7.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

8.  Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.

Authors:  Silvia de Sanjose; Yolanda Benavente; Claire M Vajdic; Eric A Engels; Lindsay M Morton; Paige M Bracci; John J Spinelli; Tongzhang Zheng; Yawei Zhang; Silvia Franceschi; Renato Talamini; Elizabeth A Holly; Andrew E Grulich; James R Cerhan; Patricia Hartge; Wendy Cozen; Paolo Boffetta; Paul Brennan; Marc Maynadié; Pierluigi Cocco; Ramon Bosch; Lenka Foretova; Anthony Staines; Nikolaus Becker; Alexandra Nieters
Journal:  Clin Gastroenterol Hepatol       Date:  2008-04       Impact factor: 11.382

9.  Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors:  Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

Review 10.  Intrinsic cellular defenses against virus infection by antiviral type I interferon.

Authors:  Kyung-Hyun Boo; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.